
    
      ING111322: A Double-Blind, Randomized, Placebo-Controlled, Repeat Dose Escalation Study to
      Investigate the Safety, Tolerability and Pharmacokinetics of GSK1349572 Followed by A Single
      Dose, Randomized, 3-Period, Balanced, Crossover Study to Assess the Relative Bioavailability
      of Two Formulations and Food Effect on GSK1349572 in Healthy Male and Female Subjects
    
  